× |
|
POLYVINYL ACETATE PHTHALATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
BAXDELA (delafloxacin meglumine) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
XYLITOL Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
POLYETHYLENE GLYCOL Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
GLYCERYL MONOSTEARATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|